# Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS)

> **NCT06345898** · EARLY_PHASE1 · RECRUITING · sponsor: **West China Hospital** · enrollment: 12 (estimated)

## Conditions studied

- X Linked Retinoschisis

## Interventions

- **DRUG:** JWK002

## Key facts

- **NCT ID:** NCT06345898
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-17
- **Primary completion:** 2033-11-30
- **Final completion:** 2033-11-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06345898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06345898, "Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06345898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*